top of page
dnusageneral.png banner clean.png

Integration of psychedelics with Mental Health  

"By next 2021, roughly 20 per cent of India will suffer from some form of mental illness"

Psychedelic Society of India, along with other organisations and individuals around the world, are calling on the Indian government to reschedule certain Psychedelics / Entheogens, a natural compound found in hundreds of species of plants that has been called a ‘breakthrough’ treatment for mental health.

Recent trials using psilocybin to treat depression and anxiety have returned staggering results, with 80% of patients reporting significantly improved wellbeing or life satisfaction for up to six months from just a single dose.

Psilocybin is currently a Schedule 1 substance. Schedule 1 substances are not authorised for medical use and can only be supplied, possessed or administered in exceptional circumstances under a special Home Office licence. This means psilocybin cannot be prescribed by doctors, and that conducting research with it is extremely time-consuming and expensive.

By rescheduling psilocybin from Schedule 1 to Schedule 2 or below, research would become faster and cheaper, and doctors would be able to start prescribing the substance when they see fit.

The Narcotic Drugs and Psychotropic Substances Act, 1985


Petition - Decriminalize the use of Psychedelics of Mental Health


To the India Ministers for Drug Policy and Mental Health,

400 million people suffer from depression & anxiety in India. Research has shown the potential of psilocybin to treat these conditions2, 3, 4, 5, yet it is being hindered by the restrictive Schedule 1 status of the substance. Out of compassion for those suffering from depression & anxiety, we ask that you take immediate action to reschedule psilocybin.

Content of Mental Health & Psychedelics

Psychedelic Psychotherapy: Using LSD, MDMA and Psilocybin to Treat Mental Health

Psychedelic Psychotherapy: Using LSD, MDMA and Psilocybin to Treat Mental Health

While psychedelic drugs such as LSD, psilocybin, and DMT are most commonly associated with recreational highs and headtrips, a groundswell of academic opinion suggests that the substances could be utilised to serve a raft of therapeutic benefits as well. In Australia, official trials of medicinal psychedelics are only just starting to get off the ground. But a small community of experimental psychotherapists—along with self-medicating users—have been using acid and mushrooms to treat mental health conditions for years, with promising results. We speak to some of the people who are at the coalface of psychedelic-assisted psychotherapy in Australia—and hear their views on how mind-expanding drugs could be the next frontier in mental health treatment. Please note that since this video was made, a medical trial using psilocybin for palliative care patients will be introduced in Melbourne, Australia. Read more: Click here to SUBSCRIBE to VICE Asia: Connect with VICE Asia: Check out our full video catalog: Videos, daily editorial and more: More videos from the VICE network: Like VICE Asia on Facebook: Follow VICE Asia on Twitter: Follow us on Instagram:
How Psychedelics Are Saving Lives

How Psychedelics Are Saving Lives

This video, produced by and, highlights how psychedelic medicines are saving lives worldwide. Numerous studies show these substances are non-neurotoxic, non-addictive and are having profound effects curing some of the most stubborn mental health disorders by helping people purge bottled up trauma. MDMA is curing debilitating PTSD in veterans. Psilocybin, the psychedelic compound in magic mushrooms, is alleviating anxiety and depression. LSD was used successfully for decades to combat alcohol addictions and anxiety. Ayahuasca is helping people purge traumatic memories while increasing serotonin levels in the brain. Psychedelics are some of the most profound medicines known to man. To learn more about these natural therapies, please visit . Video sources: UN Convention on Psychotropic Substances which made Psychedelics Illegal worldwide Study: Alcohol is Most Dangerous drug Alternet: The Hardest Drugs to Kick Ranking of Drug Harm CDC: Tobacco Mortality Rate Psychedelics Don't Cause Mental Health Problems—And They Might Keep You Sane MDMA PTSD Research: Veterans Suicide Data Report: Magic Mushroom Toxicity Caffeine or cannabis -- which drug is more dangerous? Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients with Obsessive-Compulsive Disorder, TEDx: Roland Griffiths on Psilocybin Magic mushrooms' psychedelic ingredient could help treat people with severe depression, "Magic Mushrooms" Show Signs of Helping in Addiction, Cancer Anxiety 'Magic Mushrooms' Can Improve Psychological Health Long Term, 'Magic Mushroom' Drug Shows Promise in Treating Addictions and Cancer Anxiety, Psilocybin and neurogenesis LSD vs. Alcoholism, Neurons to Nirvana LSD could help alcoholics stop drinking, AA founder believed Peyote: Psychological and cognitive effects of long-term peyote use among Native Americans, DMT The Spirit Molecule Documentary Maps Ibogaine Research A New Ayahuasca Study, Personality, Psychopathology, Life Attitudes, and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study, Human Psychopharmacology of Hoasca, A Plant Hallucinogen Used in Ritual Context in Brazil, Potent Jungle Vine Brew Has Potential to Treat Addiction, How Psychedelics unlock traumatic memories, Ayahuasca vs. PTSD Integrating the Modern Practice of Traditional Ayahuasca Shamanism
bottom of page